AXSM · Forms 3, 4, 5
Insider trades at Axsome Therapeutics, Inc.
2 insiders sold $12.6M of Axsome Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Axsome Therapeutics, Inc. (AXSM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mark L. Jacobson | Chief Operating Officer | Option exercise | 10,000 | $12.95 | $130K | Form 4 | |
| Mark L. Jacobson | Chief Operating Officer | Sell (10b5-1 plan) | 10,000 | $208.65 | $2.1M | Form 4 | |
| Herriot Tabuteau | Chief Executive Officer | Option exercise | 4,660 | $4.95 | $23K | Form 4 | |
| Herriot Tabuteau | Chief Executive Officer | Sell (10b5-1 plan) | 4,660 | $213.95 | $997K | Form 4 | |
| Herriot Tabuteau | Chief Executive Officer | Option exercise | 45,004 | $4.95 | $223K | Form 4 | |
| Herriot Tabuteau | Chief Executive Officer | Sell (10b5-1 plan) | 45,004 | $212.01 | $9.5M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.